Pfizer sues Metsera, Novo Nordisk
Digest more
There’s plenty of reason to remain bullish on Novo Nordisk. Even with the challenges it has faced recently, the company ...
Novo Nordisk A/S (NYSE:NVO) is one of the Best Bargain Stocks to Buy in November. On October 22, Reuters reported that Novo Nordisk A/S (NYSE:NVO)’s top investor, the non-profit Novo Nordisk ...
The chairman of Novo Nordisk and six other independent board members quit on Tuesday after a dispute with the company's ...
The Novo Nordisk Foundation owns 28.1% of the company's shares, but holds a three-quarter share of the voting rights, which ...
Novo Nordisk (NVO) recruits top healthcare analyst Michael Novod, a long time bull of the company, as head of its investor ...
The changing of the guard at Novo Nordisk took another turn this week as the company revealed that seven members of its board ...
Novo Nordisk today announced plans to present 11 abstracts at the 76th Annual American Association for the Study of Liver ...
Novo Nordisk (($NVO)) announced an update on their ongoing clinical study. Study Overview: Novo Nordisk is conducting a study titled ‘Wegovy® ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback